Deposition pattern of aerosolized Legionella using an ex vivo human-porcine respiratory model

S. Perinel Ragey (Cellieu, France)

Source: International Congress 2017 – From microbiology to clinical work
Session: From microbiology to clinical work
Session type: Thematic Poster
Number: 4128
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Perinel Ragey (Cellieu, France). Deposition pattern of aerosolized Legionella using an ex vivo human-porcine respiratory model. 4128

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017



Characterisation of an ex vivo model of human airway epithelium
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019


Establishing ex vivo infection to influenza A virus in mouse precision cut lung slices
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021


Pathogenic effect of intratracheal exposure on nanocarbons - in vivo study on guinea pig model
Source: Eur Respir J 2004; 24: Suppl. 48, 606s
Year: 2004

Altered pulmonary capillary permeability in immunosuppressed guinea pig infected with serum type 1 Legionella pneumophila
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019

Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019


Late Breaking Abstract - Efficient replication of respiratory syncytial virus induces a decrease of mucociliary clearance in human small airway 3D culture
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018


A human 3D tissue model of the respiratory mucosa for infection studies with Bordetella pertussis
Source: ERS Research Seminar 2016 - New developments in in vitro models of the pulmonary epithelium
Year: 2016

Improving surfactant therapy: Development of a neonatal upper airway model for in vitro aerosol deposition testing
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013

Impact of particle exposure systems on acute effects in an in vitro alveolar model
Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections
Year: 2021


Late Breaking Abstract - Development of an ex vivo pediatric preclinical model of bronchopulmonary dysplasia for aerosol regional deposition studies
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018



Characterization of murine model of chronic M. abscessus respiratory infection.
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Mouse model of pulmonary disease after aerosol infection with mycobacterium xenopi
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011


Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


A human-like ex vivo preclinical model for aerosol deposition studies
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Development of a murine model to test for respiratory sensitization potentials of chemical allergens. Respiratory and immunological changes
Source: Eur Respir J 2006; 28: Suppl. 50, 690s
Year: 2006

Development of an in vitro pulmonary translocation system for ultrafine particles
Source: Eur Respir J 2005; 26: Suppl. 49, 387s
Year: 2005

Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


Establishment of a murine asthma exacerbation model by combining OVA exposure with either RSV or influenza infection
Source: International Congress 2016 – Immune responses in the lung
Year: 2016